Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Holder

Showing results (71-80 of 86) with videos related to

Pageof 9
Sort By:
Cancer Chemotherapy and Pharmacology|January 1, 1986
Pharmacokinetic and endocrinological parameters of a slow-release depot preparation of the GnRH analogue ICI 118630 (zoladex) compared with a subcutaneous bolus and continuous subcutaneous infusion of the same drug in patients with prostatic cancerT J Perren, R N Clayton, G Blackledge, et al.
The Journal of Clinical Endocrinology and Metabolism|January 23, 2009
Medical therapy in patients with acromegaly: predictors of response and comparison of efficacy of dopamine agonists and somatostatin analoguesM Sherlock, E Fernandez-Rodriguez, A Aragon Alonso, et al.
Molecular Cancer Therapeutics|May 13, 2024
IL-15/IL-15Rα-Fc-Fusion Protein XmAb24306 Potentiates Activity of CD3 Bispecific Antibodies through Enhancing T-Cell ExpansionJi Li, Robyn Clark, Dionysos Slaga, et al.
Molecular Pharmaceutics|April 8, 2022
Generation of a Porcine Antibody Fab Fragment Using Protein Engineering to Facilitate the Evaluation of Ocular Sustained Delivery TechnologyRobert F Kelley, Devin B Tesar, Yue Wang, et al.
Chemistry & Biology|January 27, 2015
Generating site-specifically modified proteins via a versatile and stable nucleophilic carbon ligationRomas Kudirka, Robyn M Barfield, Jesse McFarland, et al.
Physical Review Letters|January 15, 2011
k Dependence of the crystal-field splittings of 4f states in rare-earth systemsD V Vyalikh, S Danzenbächer, Yu Kucherenko, et al.
Military Medicine|July 24, 2019
Influence of Time to Transport to a Higher Level Facility on the Clinical Outcomes of US Combat Casualties with TBI: A Multicenter 7-Year StudyJoseph K Maddry, Allyson A Arana, Crystal A Perez, et al.
Journal of the American Academy of Dermatology|February 21, 2026
Second Primary Cancer Risk Following Vulvar Squamous Cell Carcinoma: A SEER-Based Analysis from 2000 to 2022Hue T T Tran, Raslina Shrestha, Katherine G Holder, et al.
The Journal of Clinical Endocrinology and Metabolism|September 10, 2004
11beta-hydroxysteroid dehydrogenase type 1 activity in lean and obese males with type 2 diabetes mellitusG Valsamakis, A Anwar, J W Tomlinson, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|October 1, 2025
A quantitative systems pharmacology model to inform clinical translation of dynamic PKPD relationships of engineered IL-15Louis R Joslyn, Mohammad Jafarnejad, Rajbharan Yadav, et al.
Pageof 9

Showing results (71-80 of 86) with videos related to

Sort By:
Pageof 9
Cancer Chemotherapy and Pharmacology|January 1, 1986
Pharmacokinetic and endocrinological parameters of a slow-release depot preparation of the GnRH analogue ICI 118630 (zoladex) compared with a subcutaneous bolus and continuous subcutaneous infusion of the same drug in patients with prostatic cancerT J Perren, R N Clayton, G Blackledge, et al.
The Journal of Clinical Endocrinology and Metabolism|January 23, 2009
Medical therapy in patients with acromegaly: predictors of response and comparison of efficacy of dopamine agonists and somatostatin analoguesM Sherlock, E Fernandez-Rodriguez, A Aragon Alonso, et al.
Molecular Cancer Therapeutics|May 13, 2024
IL-15/IL-15Rα-Fc-Fusion Protein XmAb24306 Potentiates Activity of CD3 Bispecific Antibodies through Enhancing T-Cell ExpansionJi Li, Robyn Clark, Dionysos Slaga, et al.
Molecular Pharmaceutics|April 8, 2022
Generation of a Porcine Antibody Fab Fragment Using Protein Engineering to Facilitate the Evaluation of Ocular Sustained Delivery TechnologyRobert F Kelley, Devin B Tesar, Yue Wang, et al.
Chemistry & Biology|January 27, 2015
Generating site-specifically modified proteins via a versatile and stable nucleophilic carbon ligationRomas Kudirka, Robyn M Barfield, Jesse McFarland, et al.
Physical Review Letters|January 15, 2011
k Dependence of the crystal-field splittings of 4f states in rare-earth systemsD V Vyalikh, S Danzenbächer, Yu Kucherenko, et al.
Military Medicine|July 24, 2019
Influence of Time to Transport to a Higher Level Facility on the Clinical Outcomes of US Combat Casualties with TBI: A Multicenter 7-Year StudyJoseph K Maddry, Allyson A Arana, Crystal A Perez, et al.
Journal of the American Academy of Dermatology|February 21, 2026
Second Primary Cancer Risk Following Vulvar Squamous Cell Carcinoma: A SEER-Based Analysis from 2000 to 2022Hue T T Tran, Raslina Shrestha, Katherine G Holder, et al.
The Journal of Clinical Endocrinology and Metabolism|September 10, 2004
11beta-hydroxysteroid dehydrogenase type 1 activity in lean and obese males with type 2 diabetes mellitusG Valsamakis, A Anwar, J W Tomlinson, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|October 1, 2025
A quantitative systems pharmacology model to inform clinical translation of dynamic PKPD relationships of engineered IL-15Louis R Joslyn, Mohammad Jafarnejad, Rajbharan Yadav, et al.
Pageof 9